Skip to main content

Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023 at the Westin NY Grand Central in New York City.

Electromed’s management team will engage in investor 1x1s on Thursday, November 16, 2023.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  261.25
+1.55 (0.60%)
AAPL  269.03
-1.68 (-0.62%)
AMD  322.31
-0.90 (-0.28%)
BAC  51.98
-0.68 (-1.29%)
GOOG  348.60
+1.10 (0.32%)
META  667.48
-3.86 (-0.57%)
MSFT  425.31
-3.94 (-0.92%)
NVDA  210.69
-2.48 (-1.16%)
ORCL  162.70
-3.26 (-1.97%)
TSLA  374.43
-1.59 (-0.42%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.